Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor.

scientific article published on January 1993

Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/nar/BrouWASLDCT93
P356DOI10.1093/NAR/21.1.5
P932PMC publication ID309058
P698PubMed publication ID8441620
P5875ResearchGate publication ID14756931

P50authorLászló ToraQ42136955
Irwin DavidsonQ42444538
P2093author name stringJ Wu
E Scheer
S Ali
C Brou
C Lang
P Chambon
P2860cites workDr1, a TATA-binding protein-associated phosphoprotein and inhibitor of class II gene transcriptionQ24337785
The cloned human oestrogen receptor contains a mutation which alters its hormone binding propertiesQ24567487
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genesQ27860623
Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteinsQ27861094
The steroid and thyroid hormone receptor superfamilyQ27861095
Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficientlyQ28208673
Cloning, expression, and transcriptional properties of the human enhancer factor TEF-1Q28282333
Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activationQ28303864
A novel mediator between activator proteins and the RNA polymerase II transcription apparatusQ28642649
Five intermediate complexes in transcription initiation by RNA polymerase IIQ29616444
GAL4-VP16 is an unusually potent transcriptional activatorQ29616453
The human estrogen receptor has two independent nonacidic transcriptional activation functionsQ29617089
Gene regulation by steroid hormonesQ29618291
Mechanism of transcriptional activation by Sp1: evidence for coactivatorsQ29620214
The transcriptional activation function located in the hormone-binding domain of the human oestrogen receptor is not encoded in a single exonQ33564956
The chicken oestrogen receptor sequence: homology with v-erbA and the human oestrogen and glucocorticoid receptorsQ33879781
The acidic transcriptional activator GAL-VP16 acts on preformed template-committed complexesQ33937872
A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5'-TGACC-3' motifs acting synergisticallyQ48185247
Reduced binding of TFIID to transcriptionally compromised mutants of VP16.Q54251780
Factors involved in specific transcription in mammalian RNA polymerase II. Functional analysis of initiation factors IIA and IID and identification of a new factor operating at sequences downstream of the initiation site.Q54410067
The mammalian TFIID protein is present in two functionally distinct complexes.Q54689250
Expression and function of the human estrogen receptor in yeast.Q54756007
Oestradiol induction of a glucocorticoid-responsive gene by a chimaeric receptorQ59063048
Negative effect of the transcriptional activator GAL4Q59072863
Formation of stable preinitiation complexes between eukaryotic class B transcription factors and promoter sequencesQ59074628
Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targetsQ59098114
Steroid hormone receptors compete for factors that mediate their enhancer functionQ61818663
Transcriptional regulation of the HIV-1 promoter by NF-kappa B in vitroQ68111216
The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation functionQ68433333
A potent GAL4 derivative activates transcription at a distance in vitroQ68928249
Functional domains of the human estrogen receptorQ69466265
Mechanism of action of an acidic transcriptional activator in vitroQ70113517
Transcription initiated by RNA polymerase II and transcription factors from liver. Structure and action of transcription factors epsilon and tauQ70141682
RNA polymerase B (II) and general transcription factorsQ34222071
Cloning of the 62-kilodalton component of basic transcription factor BTF2.Q34338584
Activation of class II gene transcription by regulatory factors is potentiated by a novel activityQ34855093
The Drosophila EcR gene encodes an ecdysone receptor, a new member of the steroid receptor superfamilyQ34920066
In vitro squelching of activated transcription by serum response factor: evidence for a common coactivator used by multiple transcriptional activatorsQ35013886
Advances in RNA polymerase II transcriptionQ35673499
Transcription activation by estrogen and progesterone receptorsQ36468309
Factors involved in specific transcription by mammalian RNA polymerase II: role of transcription factors IIA, IID, and IIB during formation of a transcription-competent complexQ36774375
Mechanism of estrogen receptor-dependent transcription in a cell-free systemQ36775149
Identification of a coactivator that increases activation of transcription by serum response factor and GAL4-VP16 in vitroQ37053594
Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IIDQ37531197
Evidence for a factor required for transcriptional stimulation by the chimeric acidic activator GAL-VP16 in HeLa cell extractsQ37586227
Activators and targetsQ37856107
Regulation of gene expression by nuclear hormone receptorsQ38326537
Distinct classes of transcriptional activating domains function by different mechanismsQ38339126
Selective inhibition of activated but not basal transcription by the acidic activation domain of VP16: evidence for transcriptional adaptorsQ38340343
Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptorQ38341530
Identification of two transactivation domains in the mouse oestrogen receptorQ38344037
Nuclear receptors enhance our understanding of transcription regulationQ39324380
The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cellsQ41870113
Purification of a factor specific for the upstream element of the adenovirus-2 major late promoterQ42091553
Coactivators for a proline-rich activator purified from the multisubunit human TFIID complexQ42468497
Sequence-specific antirepression of histone H1-mediated inhibition of basal RNA polymerase II transcriptionQ42472464
Family of proteins that interact with TFIID and regulate promoter activityQ42473645
Physical Analysis of Transcription Preinitiation Complex Assembly on a Class II Gene PromoterQ45226839
Transcription from a TATA-less promoter requires a multisubunit TFIID complexQ46109338
The Zta trans-activator protein stabilizes TFIID association with promoter DNA by direct protein-protein interactionQ46609056
Separation and characterization of factors mediating accurate transcription by RNA polymerase II.Q47956947
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectestrogenQ277954
P304page(s)5-12
P577publication date1993-01-01
P1433published inNucleic Acids ResearchQ135122
P1476titleDifferent TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor
P478volume21

Reverse relations

cites work (P2860)
Q40792892A C-terminal domain in FosB, absent in FosB/SF and Fra-1, which is able to interact with the TATA binding protein, is required for altered cell growth.
Q35000751A TBP-containing multiprotein complex (TIF-IB) mediates transcription specificity of murine RNA polymerase I
Q42657392A cell-specific factor represses stimulation of transcription in vitro by transcriptional enhancer factor 1.
Q39722071A multiplicity of mediators: alternative forms of transcription complexes communicate with transcriptional regulators
Q37132891A transcriptionally silent RXRalpha supports early embryonic morphogenesis and heart development
Q41284016Activation function 1 of retinoic acid receptor beta 2 is an acidic activator resembling VP16.
Q37726327Biochemical analyses of nuclear receptor-dependent transcription with chromatin templates
Q28263487Characterization of the transcription activation function and the DNA binding domain of transcriptional enhancer factor-1
Q37726329Chromatin remodeling and nuclear receptor signaling.
Q27937428Cloning and characterization of an essential Saccharomyces cerevisiae gene, TAF40, which encodes yTAFII40, an RNA polymerase II-specific TATA-binding protein-associated factor
Q24315758Cloning and characterization of hTAFII18, hTAFII20 and hTAFII28: three subunits of the human transcription factor TFIID
Q24797549Coordinate regulation of RARgamma2, TBP, and TAFII135 by targeted proteolysis during retinoic acid-induced differentiation of F9 embryonal carcinoma cells
Q38295125Distamycin A and tallimustine inhibit TBP binding and basal in vitro transcription.
Q24562199Distinct domains of hTAFII100 are required for functional interaction with transcription factor TFIIF beta (RAP30) and incorporation into the TFIID complex
Q24320008Function of TAF(II)-containing complex without TBP in transcription by RNA polymerase II
Q24324051Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors
Q24321811Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor
Q28242358Interaction of estrogen receptor alpha with 3-methyladenine DNA glycosylase modulates transcription and DNA repair
Q40106128Interaction of estrogen receptor alpha with proliferating cell nuclear antigen
Q40791998Involvement of cyclic AMP response element binding protein (CREB) and estrogen receptor phosphorylation in the synergistic activation of the estrogen receptor by estradiol and protein kinase activators
Q41526912Modified steroid receptors and steroid-inducible promoters as genetic switches for gene therapy
Q34388525Multiple interactions between hTAFII55 and other TFIID subunits. Requirements for the formation of stable ternary complexes between hTAFII55 and the TATA-binding protein
Q24323091Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor
Q28910378Oestrogen receptor facilitates the formation of preinitiation complex assembly: involvement of the general transcription factor TFIIB
Q42498731Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells
Q34043346Research into Specific Modulators of Vascular Sex Hormone Receptors in the Management of Postmenopausal Cardiovascular Disease
Q71747785Retinoid-dependent in vitro transcription
Q36633683Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription f
Q33837314Selective oestrogen receptor modulation: molecular pharmacology for the millennium
Q73534497Selective oestrogen receptor modulation: molecular pharmacology for the millennium
Q40409585Sequence-specific transactivators counteract topoisomerase II-mediated inhibition of in vitro transcription by RNA polymerases I and II.
Q41104476Stimulation of transcription in vitro from a liver-specific promoter by human glucocorticoid receptor (hGRα)
Q33351996TAF6delta controls apoptosis and gene expression in the absence of p53.
Q33526062TAF6delta orchestrates an apoptotic transcriptome profile and interacts functionally with p53.
Q33958193TAFII40 protein is encoded by the e(y)1 gene: biological consequences of mutations
Q24554379The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1
Q28142781The N-terminal domain of human TAFII68 displays transactivation and oncogenic properties
Q40791117The N-terminal domain of the human TATA-binding protein plays a role in transcription from TATA-containing RNA polymerase II and III promoters
Q24291405The TFIID components human TAF(II)140 and Drosophila BIP2 (TAF(II)155) are novel metazoan homologues of yeast TAF(II)47 containing a histone fold and a PHD finger
Q40021717The X protein of hepatitis B virus coactivates potent activation domains
Q40416675The major histocompatibility complex (MHC) Ea promoter: sequences and factors at the initiation site.
Q34107355The multicoloured world of promoter recognition complexes.
Q33969106The novel transcription factor e(y)2 interacts with TAF(II)40 and potentiates transcription activation on chromatin templates
Q38308499Transcriptional activation by herpes simplex virus type 1 VP16 in vitro and its inhibition by oligopeptides
Q38298143Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein
Q34716188Trap a gene and find out its function: toward functional genomics in Drosophila
Q34055015Unique TATA-binding protein-containing complexes and cofactors involved in transcription by RNA polymerases II and III

Search more.